In pursuance of Regulation 33(3) (C ) of the LODR with Stock Exchange, please find enclosed the Limited Review Report along with the financial results for the Quarter and half year ended 30th September 2019

pdf

Bharat Immunological & Biologicals Corporation Ltd.

30 Oct 2019

20.00

-2.34%

Result

Bharat Immunologicals & Biologicals Corporation Ltd - 524663 - Outcome of Board Meeting

BSE India

In pursuance of the LODR with Stock Exchange, please find enclosed the Unaudited quarterly financial results for the quarter and half year ended September 2019 approved by the Board of the Company in its Meeting on 29.10.2019. This submission of UAFR will succeeded by XBRL filing as per the requirement of Exchange.

pdf

Bharat Immunological & Biologicals Corporation Ltd.

30 Oct 2019

20.00

-2.34%

Board Meeting

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ - 524663 - Outcome of Board Meeting

BSE India

pdf

Bharat Immunological & Biologicals Corporation Ltd.

15 Oct 2019

20.00

-2.34%

Board Meeting

Bharat Immunologicals & Biologicals Corporation Ltd - 524663 - Board Meeting Intimation for Intimation Of Date …

BSE India

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2019 ,inter alia, to consider and approve Pursuant to the Regulation 29 and other applicable Regulation(s) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is informed that a meeting of the Board of Directors of the Company is scheduled to be held on Thursday, 29th October 2019, to approve and take on record the Un-audited Quarterly Financial Results of the Company for the quarter and half year ended 30th September 2019.

pdf

Bharat Immunological & Biologicals Corporation Ltd.

15 Oct 2019

20.00

-2.34%

Company Update

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ - 524663 - Certificate From Practicing Company Secretary Under Regulation …

BSE India

In pursuance of Regulation 40 of the LODR with Stock Exchange, please find attached the Certificate from Practicing Company Secretary for the half year ended on 30th September 2019. It is requested to take the above on record please.

pdf

Bharat Immunological & Biologicals Corporation Ltd.

11 Oct 2019

20.00

-2.34%

Company Update

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ - 524663 - Shareholding for the Period Ended September 30, 2019

BSE India

Bharat Immunologicals & Biologicals Corporation Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2019. For more details, kindly Click here

Bharat Immunological & Biologicals Corporation Ltd.

11 Oct 2019

20.00

-2.34%

Company Update

Bharat Immunologicals & Biologicals Corporation Ltd - 524663 - Statement Of Investor Complaints For The Quarter Ended September 2019

BSE India

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0220 Name of the Signatory :- SANDIP KUMAR LALDesignation :- Company Secretary and Compliance Officer

Bharat Immunological & Biologicals Corporation Ltd.

01 Oct 2019

20.00

-2.34%

Corp. Note

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ - 524663 - Reg. 34 (1) Annual Report

BSE India

The Shareholders of the company in its 30th Annual General Meeting held on 27.09.2019 has approved and adopted the Annual Report for the financial year 2018-19. As per Regulation 34 of the LODR 2015, the Annual Report 2018-19 is submitted for information and taking on record please.

pdf

Bharat Immunological & Biologicals Corporation Ltd.

01 Oct 2019

20.00

-2.34%

AGM

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ - 524663 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

BSE India

Bharat Immunologicals & Biologicals Corporation Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here

No results found

Is Bharat Immunological & Biologicals Corporation Ltd. worth buying?

135 Votes:

Buy 69.63%

Sell 14.81%

Hold 15.56%

44.26% Fall from 52W High

High vol. this week

Bharat Immunological & Biologicals Corporation Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Bharat Immunological & Biologicals Corporation Ltd. on BSE